Alzheimer disease in post-menopausal women: Intervene in the critical window period
Alzheimer disease (AD) is a crippling neurodegenerative disorder. It is more common in females after menopause. Estrogen probably has a protective role in cognitive decline. Large amount of research has been carried out to see the benefits of hormone replacement therapy with regards to Alzheimer sti...
Main Authors: | Nayer Jamshed, Fouzia Firdaus Ozair, Praveen Aggarwal, Meera Ekka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Journal of Mid-Life Health |
Subjects: | |
Online Access: | http://www.jmidlifehealth.org/article.asp?issn=0976-7800;year=2014;volume=5;issue=1;spage=38;epage=40;aulast=Jamshed |
Similar Items
-
Menopause: up the stairs leading down
by: S. A. Gasparyan, et al.
Published: (2020-10-01) -
Opportunities for prevention and correction of genitourinary menopausal syndrome
by: I S Zakharov
Published: (2018-04-01) -
Experience of using MHT combined with dipyridamole in patients in the early postmenopause
by: T. M. Sokolova, et al.
Published: (2019-04-01) -
Effectiveness and safety of 17β-estradiol / drospirenon для менопаузальной гормональной терапии у пациенток с риском развития метаболического синдрома
by: N. V. Seledtsova, et al.
Published: (2016-12-01) -
THE EFFECT OF LOW-DOSE DROSPIRENONE AND 17β-ESTRADIOL FOR CORRECTION OF THE MANIFESTATIONS OF CLIMACTERIC SYNDROME IN POSTMENOPAUSAL WOMEN
by: S. A. Gasparyan, et al.
Published: (2017-12-01)